Public trial registry of the CCC-Munich

Trial TAK-954

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
TAK-954
World
Full title
:

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the
Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and
Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and
Small-Bowel Resection

World
Responsible organization
:
Chirurgie Chirurgische Klinik Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Colorectal carcinoma
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2019-05-08
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chirurgisch - Therapieart: andere

Participants
Function Prename Surname Organization
World Responsible contact Daniel Reim Chirurgie Chirurgische Klinik Ismaninger Str. 22 81675 München Germany Magnifier